刊名字顺( Alphabetical List of Journals):
Professor Ferran Barbé Professor of Respiratory Medicine, University of Lleida, Lleida, Spain
Dr Barbé completed his medical training at the University of Lleida, Spain, in 1985. He continued his training in respiratory medicine at the Hospital de Bellvitge in Barcelona. In 1992, he was awarded the Diplome D'Universite in sleep physiology by the University of Rene Descartes in Paris, France. He was Director of the Sleep Unit at the Son Dureta University Hospital in Palma de Mallorca for 14 years. In 2005, he moved to Lleida as Head of the Respiratory Department at the Arnau de Vilanova University Hospital and Professor of Respiratory Medicine at the University of Lleida.
Professor Xaver Baur Professor of Occupational and Environmental Medicine, Charité University of Medicine, Berlin, Germany
Professor Baur chaired Occupational Medicine at the University of Bochum, and was director of the Occupational (and Maritime) Institutes at the Universities of Hamburg and Bochum from 1990 until September, 2012. After his retirement at the end of September, 2012, he was awarded senior professorships at the Charité University of Medicine, Berlin, Germany; and the Haukeland University Hospital, Bergen, Norway. He is the initiator and current president of the charity European Occupational and Environmental Medicine (EOM) Society, and has been chair, co-chair, and member of several task forces of the European Respiratory Society and German scientific societies, which issue guidelines and position papers on diagnostics, management, prevention and compensation of work-related respiratory disorders, new lung function reference values, and ethical issues related to occupational medicine.
Professor Rinaldo Bellomo Professor of Medicine, University of Melbourne, Melbourne, VIC, Australia
Professor Bellomo is Director of Intensive Care Research and Staff Specialist in Intensive Care at the Austin Hospital, Melbourne, Australia. He is the current Co-Chair of the Australian and New Zealand (ANZ) Intensive Care Research Centre and the Editor in Chief of Critical Care and Resuscitation, the official journal of the ANZ College of Intensive Care Medicine. His research interests include all aspects of critical care, nephrology, sepsis, blood purification, acid-base physiology, resuscitation, and critical illness prevention. He has received more than 60 national and international awards and grants, has delivered lectures at more than 130 national and international conferences, and has published over 120 book chapters and 700 PubMed-cited papers.
Professor Demosthenes Bouros Professor and Head of Pneumonology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece
Professor Bouros graduated from the Aristotle University of Thessaloniki and completed his training in pneumonology and his PhD at the National University of Athens, Greece. He has been a research fellow at Harvard Medical School's Massachusetts General Hospital (Boston, MA, USA) and the Interstitial Lung Disease Unit, Royal Brompton Hospital (London, UK). He is currently a Professor of Pneumonology and Chief of the Pneumonology Department at the Democritus University of Thrace. He has been an active participant in the generation of international consensus documents, including those on idiopathic interstitial pneumonias. Professor Bouros is Editor of the Greek journal Pneumon and serves on the editorial board of several international journals. He has published more than 300 peer-reviewed articles. His research interests have focused on the pathogenesis and treatment of pleural disease and pulmonary fibrosis and the role of stem cells in the treatment of idiopathic pulmonary fibrosis and other chronic lung diseases.
Professor Guy Brusselle Professor of Medicine, Ghent University Hospital, Ghent, Belgium
Professor Brusselle received his medical degree in 1990 at the University of Ghent, Ghent, Belgium. Investigating the functional role of cytokines in allergic asthma, he obtained his PhD in 1997. He has a keen clinical and scientific interest in asthma (including severe asthma) and COPD, and joined the Ghent University Hospital as a respiratory physician in 2002. In 2008, he became Professor of Medicine at Ghent University, teaching the courses "Study design" and "Immunopathology of airway diseases" to medical and biomedical students. He is currently head of the Laboratory for Translational Research of Obstructive Pulmonary Diseases at Ghent University. From September 2012 onwards, he will be guideline director at the European Respiratory Society (ERS).
Professor Sonia Buist Professor Emerita of Medicine, Oregon Health and Sciences University, Portland, OR, USA
Dr Buist obtained her medical degree from St Andrews University (UK), her MD from the University of Dundee (UK), and her pulmonary subspecialty training at the University of Colorado, School of Medicine (Denver, CO, USA). She is currently Professor Emerita of Medicine at the Oregon Health and Sciences University in Portland, OR, USA. She is past President of the American Thoracic Society (ATS), past member of the GOLD Initiative (Chair 2005-07), and Director of the ATS Methods in Epidemiologic, Clinical and Operations Research (MECOR) training programme (now in four continents and 17 countries). Dr Buist was awarded the ATS Trudeau Medal in 2010 for her lifetime contribution to pulmonary medicine. Her main areas of interest are COPD and global health.
Professor Peter Calverley Professor of Respiratory Medicine, University of Liverpool, Liverpool, UK
Professor Calverley graduated from the University of Edinburgh (UK) in 1973, and his postgraduate training included a period as an MRC Clinical Fellow and a Travelling Fellowship to work in the Meakins-Christie Laboratory at McGill University, Montreal, Canada. After appointment as a Consultant Physician in Liverpool in 1985, he was appointed to a Chair in Respiratory Medicine in Liverpool in 1995. His major interests are in respiratory physiology, sleep disordered breathing, and especially COPD. He has been an Associate Editor of Thorax and The European Respiratory Journal and Clinical Science, and has served on the editorial boards of the American Journal of Respiratory and Critical Care Medicine, COPD, and Chest. He has been President of the British Thoracic Society and served on the Executive of the European Respiratory Society. He has published extensively and edited several books about COPD.
Professor Kai-Hâkon Carlsen Professor of Paediatric Respiratory Medicine and Allergology, University of Oslo, Oslo, Norway
Kai-Hâkon Carlsen is Professor of Paediatric Respiratory Medicine and Allergology at the University of Oslo and Professor of Sports Medicine at the Norwegian School of Sport Sciences, Oslo. He has served as Head of the Paediatric Assembly within the European Respiratory Society, as Chair of the European Respiratory Society School, and as Chair of the European Lung Foundation. He is a member of the Tobacco Action Committee of the American Thoracic Society. He has been Associate Editor of European Respiratory Journal, Clinical Respiratory Journal, and Acta Paediatrica, and been member of the Editorial Board of Allergy, Pediatric Allergy and Immunology, and Pediatric Pulmonology. He has written more than 200 scientific articles, and more than 30 books and book chapters. His research has focussed on childhood asthma, allergy and bronchiolitis, and asthma and bronchial hyper-responsiveness in elite athletes. He has been the centre coordinator in Oslo with the GA2LEN Network of Centres of Excellence and with the Mechanisms of the Development of ALLergy (MeDALL) project.
Professor Mario Cazzola Professor of Respiratory Medicine and Chief of the Respiratory Clinical Pharmacology Unit at the University of Rome Tor Vergata, Rome, Italy
Professor Cazzola is Professor of Respiratory Medicine and Chief of the Respiratory Clinical Pharmacology Unit at the University of Rome Tor Vergata, Rome, Italy, and Honorary Professor at the Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences, London, UK. His research interests include chronic obstructive airway disorders and their pharmacotherapy. He has published more than 300 publications in peer-reviewed journals. He serves as the Editor-in-Chief of Pulmonary Pharmacology & Therapeutics, an Associate Editor of Respiratory Medicine and Respiratory Research, and a member of various editorial boards (Drugs, COPD, Respiration). He was the Director of Postgraduate Courses at the European Respiratory Society. Currently, he is the Chairman of the Southern Europe Chapter at Interasma and of the Mediterranean COPD Forum, and a member of the steering committee of the Airway Disorders Network at the American College of Chest Physicians.
Dr James Chalmers Wellcome Trust Postdoctoral Fellow and lecturer in respiratory medicine, University of Dundee, Dundee, UK
Dr Chalmers' research and clinical interests are in respiratory infections, particularly bronchiectasis, community-acquired pneumonia, and COPD. He leads a research group investigating the mechanisms and consequences of bacterial infection in chronic lung disease, supported by grants from the Wellcome Trust, Medical Research Council, Scottish Government, and charities. He is a current member of the British Thoracic Society Science and Research committee, the European Respiratory Society long-range planning committee, and the American Thoracic Society Microbiology, Tuberculosis and Pulmonary infections programme committee. He is Editor of the European Respiratory Monograph on Community-acquired pneumonia and coordinator of the European non-cystic fibrosis bronchiectasis network (EMBARC).
Professor Kian Fan Chung Professor of Respiratory Medicine, Imperial College London, London, UK
Kian Fan Chung is Professor of Respiratory Medicine at Imperial College London, and Consultant Physician at the Royal Brompton Hospital, London, UK. He trained in internal and respiratory medicine in Oxford and London, and was MRC Visiting Scientist at the University of California, San Francisco, CA, USA. He obtained his MD in 1983, and DSc in 2001, from the University of London, UK. His research interests include airways diseases, airway smooth muscle, pulmonary effect of pollution and nanoparticles, and new treatments for cough, asthma, and COPD.
Professor Marc Decramer Professor of Respiratory Medicine, University of Leuven, Leuven, Belgium
Professor Decramer was born in Oostende, Belgium, in 1953. He received medical training at the University of Leuven, Belgium, specialising in respiratory medicine at this university and at the Meakins-Christie Laboratories, McGill University, Montreal, Canada. He is currently Professor of Medicine and Chief of the Respiratory Division at the University of Leuven. He is also the current Immediate Past President of the European Respiratory Society (ERS). His previous posts include Chairman of the Scientific Committee of ERS and Chief Editor of the European Respiratory Journal. His research interests include COPD, respiratory and peripheral muscle function, exercise physiology, rehabilitation, and pharmacotherapy. He has published more than 300 publications in peer-reviewed journals.
Professor Keertan Dheda Head of Lung Infection and Immunity Unit, University of Cape Town, Cape Town, South Africa
Professor Dheda graduated from the University of Witwatersrand, Johannesburg, South Africa, in 1992, and undertook postgraduate training at the University of KwaZulu-Natal Medical School (Durban, South Africa) and University College London (UCL; London, UK). He went on to complete his training in respiratory medicine in London and a PhD at UCL through a British Lung Foundation Fellowship. He is a consultant at the Groote Schuur Hospital in Cape Town, South Africa, and leads a research group whose main interests are the immunopathogenesis of pulmonary infections, development and validation of field-friendly tools for pulmonary infections including tuberculosis, and outcomes and epidemiology of multidrug-resistant pulmonary infections including multidrugresistant and extensively drug-resistant tuberculosis.
Professor Leonardo Fabbri Professor of Medicine, University of Modena, Modena, Italy
Professor Fabbri served as Chief Editor of European Respiratory Review and European Respiratory Monographs, and Associate Editor of the European Respiratory Journal, the American Journal of Respiratory and Critical Care Medicine, and the European Journal of Clinical Investigation. He has been Chairman and is still a member of Scientific Committee of Global Initiative on Obstructive Lung Disease (GOLD) that produces the international guidelines for COPD and comorbidities. He was President of the European Respiratory Society (ERS) in 2008-09. His research interests are asthma and COPD, and more recently complex chronic comorbidities of COPD. He has published more than 300 papers in peer-reviewed journals.
Professor Urs Frey Medical Director at the University Children's Hospital, Basel, Switzerland
Professor Frey is Chair of Paediatrics and Medical Director at the University Children's Hospital in Basel, Switzerland, and is a long-established researcher in paediatric pulmonology, particularly in asthma and developmental physiology. After an MD in Paediatrics at the University of Bern, Switzerland, he completed his postgraduate study in the USA and UK, including a PhD in Biomedical Engineering at the University of Leicester, UK. He leads a birth cohort study investigating genetic and environmental effects on infant lung development and is interested in the mathematical modelling of complex airway disease. He is the recipient of several research grants and awards, including the European Respiratory Society Romain Pauwels Asthma Research Fund Award.
Professor Peter Goldstraw Professor of Thoracic Surgery, National Heart and Lung Institute, Imperial College, London, UK
Professor Goldstraw has given more than 400 lectures at international and national conferences. He received the Price Thomas Gold Medal from the Royal College of Surgeons of England in 2004, which is awarded triennially in recognition of meritorious contributions in surgery. He has been honoured with a Lifetime Achievement Award by the British Thoracic Oncology Group in 2006, and the Society for Cardiothoracic Surgery in Great Britain and Ireland in 2010. He received honorary membership of the European Society of Thoracic Surgery (ESTS) in 2007, and the Merit Award by the International Association for the Study of Lung Cancer (IASLC) in 2007. He has published more than 290 peer-reviewed articles and 56 chapters in specialist textbooks. He chaired the IASLC Staging Project from its inception in 1998 until the publication of the seventh edition of TNM in 2009. He is a board member and President of IASLC.
Dr MeiLan Han Associate Professor of Medicine, University of Michigan, Ann Arbor, MI, USA
Dr Han completed her medical degree at the University of Washington in Seattle, WA, USA. She continued her residency training in internal medicine as well as her pulmonary and critical care fellowship at the University of Michigan. She completed a Master’s degree in biostatistics and clinical study design at the University of Michigan School of Public Health (Ann Arbor, MI, USA). She serves as an Associate Editor for Thorax and sits on the editorial board for the Journal of the COPD Foundation. She also sits on the scientific advisory boards for the American Thoracic Society, American Lung Association, and COPD Foundation. She is also a member of the SPIROMICS and COPDGene steering committees. Her primary research interest centres on COPD.
Professor Anthony Harries Senior Advisor, International Union against Tuberculosis and Lung Disease, Paris, France
Professor Harries is Senior Advisor at the International Union against Tuberculosis and Lung Disease in France (since 2008) and an Honorary Professor at the London School of Hygiene and Tropical Medicine in the UK. He qualified in medicine from Cambridge University and Saint Bartholomew's Hospital in 1975, and is a registered specialist in infectious diseases and tropical medicine in the UK. From 1983 to 2008, he lived and worked in sub-Saharan Africa, first in northeast Nigeria and then in Malawi, where he was consecutively Consultant Physician, Foundation Professor of Medicine at the new medical school in Blantyre, National Advisor to the Malawi Tuberculosis Control Programme, and National Advisor in HIV care and treatment in the Ministry of Health. His main interests are tuberculosis, HIV/AIDS, tropical medicine, and operational research.
Professor Niels Høiby Professor of Medical Microbiology, University of Copenhagen, Copenhagen, Denmark
Professor Høiby graduated from the University of Copenhagen Medical School, Denmark, in 1968, and completed his training as a specialist in clinical microbiology in 1979. In 1980, he became Chairman of the Department of Clinical Microbiology at Rigshospitalet (Copenhagen University Hospital) and also Professor of Medical Microbiology in 1988. He is the Founder and Chairman of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Biofilms. He is an Editor of the Journal of Cystic Fibrosis and Biofilms, and has published extensively in the area of chronic lung infection in cystic fibrosis and other biofilm infections.
Professor Stephen Holgate Medical Research Council Clinical Professor of Immunopharmacology, Faculty of Medicine, Southampton, UK
After completing his medical training in London, UK, Professor Holgate spent 2 years at Harvard Medical School (Boston, MA, USA) to acquire skills in allergic disease mechanisms. On returning to Southampton, UK, in 1980, he set up a research group focused on the mechanisms of asthma that has resulted in more than 980 peer-reviewed publications. He is a past President of the British Society of Allergy and Clinical Immunology and British Thoracic Society, and is currently Chair of the European Respiratory Society Scientific Committee.
Professor Christine Jenkins Clinical Professor and Head of Respiratory Discipline, University of Sydney, Sydney, NSW, Australi
Professor Jenkins is a Senior Staff Specialist in the Department of Thoracic Medicine, Concord Hospital, Sydney, and Clinical Professor and Head of Respiratory Discipline, University of Sydney. After a long period of involvement in clinical trials at the Woolcock Institute of Medical Research (Glebe, NSW, Australia), she is now Head of Respiratory Trials at The George Institute in Sydney. Professor Jenkins' main research interest is the clinical management of airways disease. She has contributed to national and international clinical guidelines in asthma and COPD, and is actively involved in health policy and best practice relating to asthma and COPD. Her current research focuses on interventions in older people with asthma and COPD, patient education, pulmonary rehabilitation, persistently symptomatic asthma, and patient-centred outcomes.
Professor Keith P Klugman Professor of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA
Professor Klugman is the William H Foege Chair of Global Health at Emory University, Atlanta, GA, USA. He is also Co-Director of the Respiratory and Meningeal Pathogens Research Unit of the University of the Witwatersrand, Johannesburg, South Africa. Professor Klugman is the President of the International Society of Infectious Diseases, and past Chair of the International Board of the American Society for Microbiology. He has chaired expert committees for WHO and the Wellcome Trust. He has published more than 450 research papers on pneumonia, meningitis, antimicrobial resistance, and vaccines for bacterial pathogens, particularly the pneumococcus.
Professor Irene Marthe Lang Professor of Vascular Biology, Medical University of Vienna, Vienna, Austria
Professor Lang completed her medical education and residency at the University of Vienna, Austria, before taking on a 5-year postdoctoral research fellowship at the University of California, USA, which included a joint appointment with the Scripps Research Institute, California. Since 2004, she has been Professor of Vascular Biology at the Medical University of Vienna. Professor Lang is leading a clinical and experimental group in vascular medicine, focusing on pulmonary vascular biology and right ventricular function. She is an active interventional and structural cardiologist, and was nominated by the World Medical Association as "Caring Physician of the World" in 2006. She is currently Past-President of the Austrian Society of Cardiology, and is part of the International CTEPH Association (ICA). The objectives of the ICA include increasing awareness for CTEPH and fostering worldwide collaboration among CTEPH centres to facilitate training and advance research and education in CTEPH.
Professor Fernando D Martinez Director of the Arizona Respiratory Center, University of Arizona, Tucson, AZ, USA
Professor Martinez graduated from the University of Rome Medical School, Italy, where he also completed his training in paediatrics. He has been at the University of Arizona in Tucson, AZ, USA, since 1987, where he is Regents' Professor (the University's highest academic qualification). He is currently Director of the Arizona Respiratory Center and of the interdisciplinary BIO5 Institute. His main research interests are natural history, genetics, and treatment of childhood asthma. He was awarded the Amberson Lecture for the American Thoracic Society in 2008, for his major contributions to pulmonary science and clinical practice.
Professor Fernando J Martinez Executive Vice Chair, Department of Medicine, Weill Cornell Medical Center, New York, NY
Professor Martinez graduated from the University of Florida School of Medicine in 1983, and completed his medical training at Harvard Medical School's Beth Israel Hospital (Boston, MA, USA) and his pulmonary training at Boston University. He completed a Masters degree in biostatistics and clinical study design at the University of Michigan School of Public Health, Ann Arbor, MI, USA. He has been actively involved in the care and study of patients with COPD and fibrosing parenchymal disorders. He has been an active participant in the generation of several international consensus statements in COPD and interstitial pneumonias. He is currently the Executive Vice Chair, Department of Medicine at Weill Cornell Medical Center.
Professor Tetsuya Mitsudomi Professor of Surgery, Kinki University School of Medicine, Osaka, Japan
Professor Mitsudomi has been a Professor at the Department of Surgery, Kinki University School of Medicine in Osaka, Japan, since May, 2012. Previously he was Vice Director of Aichi Cancer Center and Chief of the Department of Thoracic Surgery. His current research interests include surgical treatment of lung cancer and individualised treatment of lung cancer based on cancer genotype such as EGFR mutations or ALK translocations. He has published more than 250 papers that have featured in international peer-reviewed journals. He is a recipient of Shinoi-Kawai Award from the Japan Lung Cancer Society (2001) and JCA-Mauvernay Award from the Japanese Cancer Association (2005)
Professor Kim Mulholland Professor of Child Health and Vaccinology, London School of Hygiene and Tropical Medicine, London, UK; Menzies School of Health Research, Darwin, NT, Australia; and Murdoch Children's Research Institute, Melbourne, VIC, Australia
Professor Mulholland graduated from University of Melbourne School of Medicine in 1976. After working in India, the UK, and Sudan, he undertook specialist paediatric training at the Royal Children's Hospital, Melbourne, Australia, between 1982 and 1988. From 1989, he worked for 6 years at the MRC Gambia Unit, undertaking research into pneumonia prevention (with vaccines) and pneumonia epidemiology and aetiology. He then spent 5 years at WHO in Geneva, where he was responsible for areas of child health research including Hib and pneumococcal vaccine research and pneumonia treatment. Since 2000, he has developed an international research programme focused on child survival, childhood pneumonia, and the use of new vaccines in developing countries, from institutional bases in the UK and Australia.
Professor David Price Primary Care Respiratory Society Professor, University of Aberdeen, Aberdeen, UK
Professor Price is the Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen, UK, and Affiliate Associate Professor in the Department of General Practice at the University of Adelaide, Australia. He completed his medical degree at the University of Cambridge (UK) in 1984, and his general practitioner training in Norwich (UK) in 1989, where he worked as a GP Principal until 2000. He now works in the Norfolk community-based respiratory and allergy service. He is a member of the executive committees for the international Allergic Rhinitis and its Impact on Asthma (ARIA) and European Association of Patients Organisations of Sarcoidosis and other Granulomatous Disorders (EPOS) guidelines groups. He is extensively involved in respiratory and allergy research; his areas of special interest are real-life effectiveness and cost-effectiveness of interventions, clinical trial design, compliance, and patients' attitudes to their disease. He has authored more than 230 peer-reviewed publications since 2000, and is responsible for approximately US$12 million in research and clinical development gran
Professor Klaus F Professor of Pulmonary Medicine, University of Kiel, Kiel, Germany
Professor Rabe graduated from the University of Hamburg, Germany, in 1983, and continued his clinical education in pulmonology, spending time in intensive care, endoscopic units, and clinical research. In 2010, he moved into his current position as Professor of Pulmonary Medicine at the University of Kiel and Director of the Department of Pneumology at Clinic Grosshansdorf, Germany. He has served on various editorial boards, was the first European Associate Editor of the American Journal of Respiratory and Critical Care Medicine, and has been Chief Editor of the European Respiratory Journal. His current scientific interests are related to large clinical trials in COPD and asthma, the mechanisms of airway inflammation, and the endoscopic staging of lung cancer. Professor Rabe has served on GINA and GOLD, and is member of the German and Dutch Chest Societies, the British Pharmacological Society, the American Thoracic Society, and the European Respiratory Society, where he currently holds the position of President.
Professor Ganesh Raghu Professor of Medicine, University of Washington Medical Center, Seattle, WA, USA
Professor Raghu received his medical degree from the University of Mysore, India. Following his postgraduate training in Internal Medicine at the University of Bangalore, India, he did his residency in General and Chest Medicine at Hartlepool General Hospital and the University of Newcastle Upon Tyne, England. He furthered his residency training in internal medicine at the State University of New York, Buffalo, NY, USA. He then undertook a fellowship in pulmonary diseases, critical care medicine and cell biology at the University of Washington in Seattle, where he has been based since, and is now Professor of Medicine and Laboratory Medicine (adjunct). He is Director of the Interstitial Lung Disease, Sarcoidosis and Pulmonary Fibrosis Program and Co-Director of the Scleroderma Clinic at the University of Washington Medical Center. Professor Raghu has devoted his career to basic and clinical sciences and clinical studies in the fields of interstitial lung disease, idiopathic pulmonary fibrosis and sarcoid and has authored over 175 publications in these areas. He serves on several national and international committees pertinent to the fields of idiopathic pulmonary fibrosis, sarcoidosis and lung transplantation.
Professor Bonnie Ramsey Director, Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, WA, US
Dr Ramsey is a graduate of Harvard School of Medicine, Boston, MA, USA, and her work focuses on development of novel therapies for treatment of cystic fibrosis lung disease with particular interest in initial infection with Pseudomonas aeruginosa. She was the lead investigator for development of inhaled tobramycin in the 1990s, and recently the lead investigator for development of ivacaftor, a novel potentiator that opens the dysfunctional CFTR protein channel in patients with cystic fibrosis and the G551D mutation. She is co-Principal Investigator of the NIDDK-supported Cystic Fibrosis Research and Translational P-30 Center, and Director of the Cystic Fibrosis Foundation Therapeutic Development Network Coordinating Center, which is responsible for the conduct of cystic fibrosis related clinical trials in the USA.
Professor Felix Ratjen Division Head for Paediatric Respiratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada
Dr Ratjen trained in Paediatric Respiratory Medicine at the University Hospital in Essen, Germany, and the Children's Hospital in Boston, MA, USA. He is currently the Division Head for Paediatric Respiratory Medicine at The Hospital for Sick Children in Toronto, Canada. His research interests include early intervention strategies in paediatric lung diseases and physiological tests to assess early lung disease. A major focus of his research is in cystic fibrosis lung disease, for which he leads several trials into new therapeutic interventions.
Professor Gordon Rubenfeld Professor of Medicine, University of Toronto, Toronto, ON, Canada
Professor Rubenfeld trained in internal medicine at Duke University, Durham, NC, USA; pulmonary and critical care medicine at the University of Washington in Seattle, WA, USA; and completed the Robert Wood Johnson Clinical Scholar programme at the University of California in San Francisco, CA, USA. He is Chief of the Trauma, Emergency, and Critical Care Program at Sunnybrook Health Sciences Centre in Toronto. Dr Rubenfeld's research interests include the clinical epidemiology of acute respiratory distress syndrome and critical illness, interventions to improve long-term outcomes after critical illness, and tools to translate research into practice in the intensive-care unit.
Dr Sundeep Salvi Director, Chest Research Foundation, Pune, Indi
Dr Salvi trained as a Respiratory Physician from the University of Pune in India, and then obtained a PhD in Clinical Medicine from the University of Southampton in the UK. He has a special interest in understanding the effects of indoor and outdoor air pollution on lung health, with a particular emphasis on airways diseases. He heads the Chest Research Foundation in Pune, India, where he has done some pioneering research in asthma and COPD. His work on COPD in non-smokers is known globally. He is a recipient of several national and international orations and awards.
Professor Malcolm R Sears Professor of Medicine, McMaster University, Hamilton, ON, Canada
Professor Sears graduated from the University of Otago, Dunedin, New Zealand, undertook postgraduate education focusing on respiratory medicine there and at the University of Washington, Seattle, WA, USA. He was a faculty member at the University of Otago until 1990, when he was recruited to McMaster University, Hamilton, ON, Canada, as Director of the Firestone Institute for Respiratory Health. He holds fellowships with the Royal Australasian College of Physicians, the Royal College of Physicians and Surgeons of Canada, and the American Academy of Asthma, Allergy and Immunology. His major research interests are longitudinal studies of the development and natural history of asthma, asthma exacerbations and mortality, and asthma management. Currently he is the principal investigator for the Canadian Healthy Infant Longitudinal Development (CHILD) birth cohort study examining origins of allergy, asthma, and other non-communicable diseases.
Dr David Serisier Associate Professor of Medicine, University of Queensland, South Brisbane, QLD, Australia
Dr Serisier is Director of the Adult Cystic Fibrosis Unit and the Department of Respiratory Medicine at the Mater Adult Hospital, Brisbane, QLD, Australia; Co-Team Leader of the Immunity, Infection and Inflammation Program at the Mater Research Institute—University of Queensland; and current Chairman of the Lung Foundation of Australia. After completing respiratory specialty training in Brisbane, Australia, Dr Serisier obtained his postgraduate Doctor of Medicine from the University of Southampton, UK, in 2005. His research interests are in infective lung diseases, particularly in cystic fibrosis and non-cystic fibrosis bronchiectasis, and the interplay between chronic infection and inflammation.
Professor Renato Stein Pediatric Pulmonary Unit, Pontificia Univeridade Católica RS, Porto Alegre, Brazil
Professor Stein graduated from Medicine in 1979, in Porto Alegre, Brazil. After his residency in Paediatrics, he became a fellow in the Pediatric Pulmonary Service in Toronto, Canada, at The Hospital for Sick Children. In 1994, Dr Stein was a research fellow at the University of Arizona, USA, under the guidance of Fernando Martinez, until 1998. During this time a series of seminal studies on the role of early respiratory viral infections and its relation with asthma were published. On his return to Brazil, Dr Stein established a research team, with a focus in both population-based and experimental studies on the role of early life viral infections in acute and recurrent respiratory events leading to asthma. Dr Stein is an Associate Editor of the Brazilian Journal of Respiratory Medicine and serves on the editorial board of several international journals in the specialty.
Dr Thomas Stinchcombe Associate Professor Internal Medicine, University of North Carolina, Chapel Hill, NC, USA
Dr Stinchcombe completed medical school at the University of Virginia, his internal medicine residency at the University of Michigan, and his haematology and oncology fellowship at the University of North Carolina. His clinical interest is in thoracic malignancies, and his research focus is clinical trials for non-small-cell and small-cell lung cancer. He is Associate Professor in the Department of Internal Medicine, a member of Lineberger Comprehensive Cancer Center, and co-Director of Thoracic Oncology Program at the University of North Carolina, Chapel Hill, NC, USA. He is a member of the Respiratory Committee of the Alliance Cooperative Trials Group.
Professor Erika von Mutius Head of Department of Asthma and Allergies, Dr von Hauner University Children's Hospital, Munich, Germany
Professor von Mutius is a paediatrician, allergologist, and epidemiologist. She is head of the Childhood Allergy and Asthma Research Group and the Department of Asthma and Allergies at the Dr von Hauner University Children's Hospital in Munich, Germany. Dr von Mutius' working group has longstanding experience with design, implementation, and data analysis of large, multicentre, and interdisciplinary projects addressing the role of genetic and environmental risk factors for the development of asthma and allergic illnesses.
Dr Heather Wakelee Associate Professor of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA
Dr Heather Wakelee is an Associate Professor of Medicine at Stanford University in the Division of Oncology, where she leads the lung cancer medical oncology research programme and has been an author of more than 80 medical articles on lung cancer and related topics. She trained at Princeton University (Princeton, NJ, USA) as an undergraduate, and then attended Johns Hopkins University Medical School (Baltimore, MD, USA) before completing her residency and fellowship at Stanford University. Dr Wakelee's focus is in clinical research in lung cancer and other thoracic malignancies. Dr Wakelee has led several investigator-initiated protocols investigating bevacizumab and other antiangiogenic agents. Other pathways of interest include EGFR-targeted drugs, especially agents designed to overcome resistance and other molecularly targeted agents. She has also worked extensively in the areas of lung cancer in never-smokers and sex differences in lung cancer.
Professor Sally Wenzel Professor of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
Professor Wenzel graduated from the University of Florida School of Medicine in 1981. She did her residency at Wake Forest University (Winston-Salem, NC, USA) and her pulmonary fellowship at Virginia Commonwealth University (Richmond, VA, USA). She spent 19 years at the National Jewish Health in Denver before moving to the University of Pittsburgh. She is director of the University of Pittsburgh Asthma Institute@UPMC/UPSOM. She has been actively involved in research and clinical care of asthma and other airway diseases for more than 25 years, and has published more than 150 peer-reviewed articles. Her research interests have focused on asthma heterogeneity and the role of mast cell and the epithelium. She has been actively involved in the American Thoracic Society (ATS) and the American Academy of Allergy Asthma and Immunology. She received the ATS Recognition Award for Scientific Accomplishments in 2010.
Professor Nanshan Zhong Professor of Medicine, Guangzhou Medical College, Guangzhou, China
Professor Zhong holds the posts of Director of Guangzhou Institute of Respiratory Diseases, First Affiliated Hospital of Guangzhou Medical College, and Director-General of China State Key Laboratory of Respiratory Diseases. He is a leader and principal investigator in more than ten major scientific projects. He has published many papers in worldwide reputed journals, including Nature Medicine, The Lancet, BMJ, and American Journal of Respiratory and Critical Care Medicine, and more than 200 papers in state-level journals. His publications have received 438 citations. Over the past decades, Professor Zhong has been a leader in promotion of China's respiratory medicine towards the forefront of international advances. He has organised and participated in the development of several Chinese guidelines for diagnosis and management of bronchial asthma, COPD, chronic cough, severe acute respiratory syndrome, and high-pathogenic avian influenza.
返回页首 